Thursday, August 4, 2011
Cephalon Inc., of Frazer, Pa., reported second quarter net sales of $730.1 million, a 2 percent increase over the second quarter of 2010, including $332.3 million for its central nervous system franchise, $140.6 million for its pain franchise and $158.8 million for its oncology franchise.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.